Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
SBFM
Sunshine Biopharma, Inc.
K1.1 mRNA liver cancer program places the company in liver disease therapeutics.
|
$5.56M |
$1.24
+1.64%
|
|
IBO
Impact BioMedical Inc.
Linebacker is an oncology-focused platform of electrophilically enhanced polyphenol compounds licensed for development and commercialization.
|
$5.50M |
$0.45
-4.63%
|
|
SSKN
STRATA Skin Sciences, Inc.
STRATA's core offerings are dermatology-focused excimer laser systems and related medical devices (XTRAC, Pharos lasers; VTRAC lamp systems; TheraClear X), which are medical devices and equipment.
|
$5.42M |
$1.31
+1.94%
|
|
SNOA
Sonoma Pharmaceuticals, Inc.
Company offers HOCl-based wound care products that function as wound care solutions/devices.
|
$5.41M |
$3.35
+2.45%
|
|
DFCO
Dalrada Financial Corporation
Infusion pharmacy and compounding facility fall under healthcare services & facilities.
|
$5.38M |
$0.03
|
|
BIXT
Bioxytran, Inc.
MDX Viewer is an FDA-approved diagnostic device that measures tissue oxygenation and provides real-time metabolic insights; a direct product/service Bioxytran provides.
|
$5.34M |
$0.07
|
|
LQMT
Liquidmetal Technologies, Inc.
Medical Device Components: Liquidmetal designs/manufactures customized components for medical devices using its amorphous alloys.
|
$5.22M |
$0.13
|
|
APRE
Aprea Therapeutics, Inc.
APRE is an oncology-focused biotech developing cancer therapies, namely DDR inhibitors, which aligns with Biotech - Oncology.
|
$5.18M |
$0.90
+0.12%
|
|
CELZ
Creative Medical Technology Holdings, Inc.
CELZ develops autologous/allogeneic cell therapies (ImmCelz and AlloStem), a core cell therapy business.
|
$5.16M |
$2.02
+6.32%
|
|
ALBT
Avalon GloboCare Corp.
KetoAir breathalyzer is a directly produced diagnostic equipment device sold as a precision diagnostic product.
|
$5.14M |
$1.06
-20.52%
|
|
CPHI
China Pharma Holdings, Inc.
Core product: generic drugs manufacturing (Helpson's portfolio in PRC).
|
$5.07M |
$1.55
-0.26%
|
|
INBS
Intelligent Bio Solutions Inc.
INBS directly develops and sells the Intelligent Fingerprinting Platform, a diagnostic device for non-invasive drug screening (fingerprint sweat-based testing) and associated cartridges/readers.
|
$4.94M |
$5.97
+8.55%
|
|
CLDI
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics directly develops cancer therapies (oncolytic virus platforms) targeting oncology indications.
|
$4.92M |
$1.02
-1.92%
|
|
PAVM
PAVmed Inc.
EsoGuard and EsoCheck are proprietary diagnostic devices/tests used for esophageal precancer detection, a direct diagnostic equipment product line.
|
$4.81M |
$6.45
-26.29%
|
|
KALA
KALA BIO, Inc.
KPI-012 is a mesenchymal stem cell secretome (MSC-S) therapy, aligning with Biotech - Cell Therapy.
|
$4.74M |
$0.67
+10.80%
|
|
CYCN
Cyclerion Therapeutics, Inc.
Cyclerion is centered on neuropsychiatric drug development, specifically an individualized therapy for Treatment Resistant Depression (TRD).
|
$4.54M |
$1.41
+3.31%
|
|
NAOV
NanoVibronix, Inc.
Core business is medical devices, including legacy wound/pain therapies and new ENvue enteral-feeding technology.
|
$4.37M |
$4.06
-5.80%
|
|
ADMT
ADM Tronics Unlimited, Inc.
Company designs and manufactures medical devices and biometric sensing technologies including diagnostics and therapeutics.
|
$4.35M |
$0.10
|
|
POAI
Predictive Oncology Inc.
Biotech - Oncology focus via proprietary biobank, wet-lab validation, and AI-enabled oncology drug discovery.
|
$4.32M |
$5.94
-0.17%
|
|
TTNP
Titan Pharmaceuticals, Inc.
Titan's core ProNeura technology is a long-acting drug delivery platform used for subdermal implants.
|
$4.21M |
$4.61
|
|
ACXP
Acurx Pharmaceuticals, Inc.
Lead product ibezapolstat is an oral small-molecule antibiotic for CDI, aligning with the 'Oral Small Molecule Therapeutics' investable theme.
|
$4.20M |
$2.69
-0.19%
|
|
PPCB
Propanc Biopharma, Inc.
Propanc Biopharma is a development-stage biotechnology company focusing on oncology therapies, making PRP its core candidate.
|
$4.01M |
$0.31
-10.90%
|
|
SONN
Sonnet BioTherapeutics Holdings, Inc.
Sonnet's core pipeline is oncology-focused immunotherapies (e.g., SON-1010 IL-12) leveraging the FHAB platform.
|
$3.99M |
$1.28
+1.98%
|
|
HCWC
Healthy Choice Wellness Corp.
HCWC runs licensed wellness centers offering services such as IV nutrient drips, i.e., Healthcare Services & Facilities.
|
$3.98M |
$0.30
-43.17%
|
|
BCLI
Brainstorm Cell Therapeutics Inc.
NurOwn is a proprietary autologous cell therapy platform developed by Brainstorm for ALS and related neurodegenerative indications, directly produced and administered by the company.
|
$3.82M |
$0.59
|
|
OGEN
Oragenics, Inc.
ONP-002 uses a proprietary intranasal drug-delivery platform (powder formulation + breath-propelled device).
|
$3.77M |
$0.95
+2.56%
|
|
PHGE
BiomX Inc.
BiomX leverages a drug delivery platform (BOLT) to rapidly assemble phage cocktails and targeted therapies.
|
$3.74M |
$2.60
-0.38%
|
|
LADX
LadRx Corporation
LadRx is a biotechnology company focused on oncology drug development.
|
$3.70M |
$0.11
|
|
GTCH
GBT Technologies Inc.
GTCH's qTerm device and biometrics relate to medical devices/biometrics category.
|
$3.70M |
$0.00
|
|
AIM
AIM ImmunoTech Inc.
Ampligen is AIM ImmunoTech's flagship oncology/immunotherapy platform and is being developed with cancer indications (pancreatic and ovarian cancer) in combination with checkpoint inhibitors.
|
$3.63M |
$1.34
|
|
HSDT
Solana Company
PoNS is a non-invasive neuromodulation device produced by the company for gait and balance rehabilitation.
|
$3.55M |
$3.31
+6.61%
|
|
SILO
Silo Pharma, Inc.
Drug Delivery Platforms directly describes Silo's intranasal and implantable drug delivery technologies (SPC-15, SPC-14, SP-26).
|
$3.55M |
$0.38
-1.00%
|
|
NAKA
Kindly MD, Inc.
Provides patient-first healthcare services and operates clinics/delivery of care under KindlyMD.
|
$3.47M |
$0.46
-5.66%
|
|
LYRA
Lyra Therapeutics, Inc.
XTreo drug-delivery platform is Lyra's core product, enabling six months of localized drug therapy via in-office implant (LYR-210).
|
$3.27M |
$1.98
+1.54%
|
|
CDIO
Cardio Diagnostics Holdings, Inc.
Provides laboratory testing services and advisory support for diagnostics.
|
$3.19M |
$1.82
+3.41%
|
|
VERO
Venus Concept Inc.
Venus Concept produces medical aesthetic devices and robotic systems (Venus platforms, ARTAS iX) and related medical devices.
|
$3.10M |
$2.23
+33.23%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$3.10M |
$0.63
+4.38%
|
Showing page 36 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
